Acutaas Chemicals granted process patent for 2,4-dimethylthiophenol
- Patent granted for 2,4-dimethylthiophenol preparation process
- Total patents held by company now stand at 11
- Patent term is 20 years from filing date in 2017
- Disclosure made under SEBI LODR Regulation 30

*this image is generated using AI for illustrative purposes only.
Acutaas Chemicals received a process patent from the Indian Patent Office on September 10, 2026. The approval covers a method for preparing 2,4-dimethylthiophenol, developed at the company’s internal R&D centre.
The patent is valid for 20 years from the filing date of September 21, 2017. This grant raises Acutaas Chemicals’ total portfolio to 11 patents for innovative processes and technology.
The company disclosed the development under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The intimation was issued to both the BSE and NSE listing departments.
What the Numbers Show
The accumulation of 11 patents indicates a sustained focus on indigenous process innovation. With the latest patent covering a specific chemical preparation method, the company reinforces its technical moat in specialty chemicals.
Historical Stock Returns for Acutaas Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +6.47% | +10.10% | +4.65% | +60.19% | +129.50% | 0.0% |
How will the commercialization of the 2,4-dimethylthiophenol process impact Acutaas Chemicals' revenue streams in the upcoming fiscal quarters?
Does this new patent provide a significant competitive advantage against global specialty chemical manufacturers, and if so, in which specific end-use industries?
What is the estimated timeline for scaling up production of 2,4-dimethylthiophenol from R&D to full-scale manufacturing?

































